foy 251 has been researched along with 4-aminobenzamidine in 1 studies
*4-aminobenzamidine: a urokinase inhibitor; inhibits acrosin; structure given in first source [MeSH]
*4-aminobenzamidine: a urokinase inhibitor; inhibits acrosin; structure given in first source [MeSH]
| Studies (foy 251) | Trials (foy 251) | Recent Studies (post-2010) (foy 251) | Studies (4-aminobenzamidine) | Trials (4-aminobenzamidine) | Recent Studies (post-2010) (4-aminobenzamidine) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 104 | 0 | 22 |
| Protein | Taxonomy | foy 251 (IC50) | 4-aminobenzamidine (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yonezawa, H | 1 |
1 other study(ies) available for foy 251 and 4-aminobenzamidine
| Article | Year |
|---|---|
Discrepancy between the potency of various trypsin inhibitors to inhibit trypsin activity and the potency to release biologically active cholecystokinin-pancreozymin.
Topics: Animals; Benzamidines; Cholecystokinin; Duodenum; Esters; Gabexate; Guanidines; Male; Pancreas; Rats; Rats, Inbred Strains; Stimulation, Chemical; Trypsin Inhibitors | 1984 |